PRDX6 attenuates oxidative stress- and TGF -induced abnormalities of human trabecular meshwork cells

Oxidative stress and TGF -induced disturbance of cells and tissues are implicated in initiation and progression of pathophysiology of cells/tissues. Using primary human Trabecular Meshwork (TM) cells from normal and glaucomatous subjects, this study demonstrated that peroxiredoxin (PRDX) 6, an antio...

Full description

Saved in:
Bibliographic Details
Published inFree radical research Vol. 43; no. 9; pp. 783 - 795
Main Authors Fatma, Nigar, Kubo, Eri, Toris, Carol B., Stamer, W. D., Camras, Carl B., Singh, Dhirendra P.
Format Journal Article
LanguageEnglish
Published Informa UK Ltd 2009
Online AccessGet full text
ISSN1071-5762
1029-2470
DOI10.1080/10715760903062887

Cover

More Information
Summary:Oxidative stress and TGF -induced disturbance of cells and tissues are implicated in initiation and progression of pathophysiology of cells/tissues. Using primary human Trabecular Meshwork (TM) cells from normal and glaucomatous subjects, this study demonstrated that peroxiredoxin (PRDX) 6, an antioxidant, offsets the deleterious effects of oxidative stress on TM cells by optimizing ROS and TGF levels. An analysis of glaucomatous TM cells revealed a reduced expression of PRDX6 mRNA and protein. Biochemical assays disclosed enhanced levels of ROS, as well as high levels of TGF s and these cells expressed elevated extracellular matrix (ECM) and Tsp1 proteins with reduced MMP2; conditions implicated in the pathophysiology of glaucoma. Non-glaucomatous TM cells exposed to TGF s/ROS showed similar features as in glaucomatous cells. The abnormalities induced were reversed by delivery of PRDX6. The data provide evidence that oxidative stress-induced abnormality in TM may be related to reduced PRDX6 expression and provide a foundation for antioxidant-based therapeutics for treating glaucoma.
ISSN:1071-5762
1029-2470
DOI:10.1080/10715760903062887